Imaging of prostate cancer with PET/CT using 18F-Fluorocholine

Vali, Reza, Loidl, Wolfgang, Pirich, Christian, Langesteger, Werner and Beheshti, Mohsen (2015) Imaging of prostate cancer with PET/CT using 18F-Fluorocholine. American journal of nuclear medicine and molecular imaging, 5 (2). pp. 96-108. ISSN 2160-8407

[thumbnail of Imaging of prostate cancer with PET/CT using 18F-Fluorocholine] Text (Imaging of prostate cancer with PET/CT using 18F-Fluorocholine)
5 - 2015 Vali AJNMMI.pdf
Restricted to Registered users only

Download (1MB)


While (18)F-Fluorodeoxyglucose ((18)F-FDG) Positron-Emission Tomography (PET) has limited value in prostate cancer (PCa), it may be useful for specific subgroups of PCa patients with hormone-resistant poorly differentiated cell types. (18)F-Fluorocholine ((18)F-FCH) PET/CT has been increasingly used in primary and recurrent PCa and has been shown to add valuable information. Although there is a correlation between the foci of activity and the areas of malignancy in the prostate gland, the clinical value of (18)F-FCH is still controversial for detection of the malignant focus in the prostate. For the T-staging of PCa at diagnosis the value of (18)F-FCH is limited. This is probably due to limited resolution of PET system and positive findings in benign prostate diseases. Conversely, (18)F-FCH PET/CT is a promising imaging modality for the delineation of local and distant nodal recurrence and bone metastases and is poised to have an impact on therapy management. In this review, recent studies of (18)F-FCH PET/CT in PCa are summarized.
Item Type: Fachpublikation (peer reviewed)
Divisions: Ordensklinikum Linz Barmherzige Schwestern > Nuklearmedizin
Depositing User: Prof. Werner Langsteger
Date Deposited: 19 Mar 2019 11:51
Last Modified: 19 Mar 2019 11:51

Actions (login required)

View Item
View Item